Skip to main content
Erschienen in: Diabetologia 8/2012

01.08.2012 | Short Communication

Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase

verfasst von: C. C. Patterson, E. Gyürüs, J. Rosenbauer, O. Cinek, A. Neu, E. Schober, R. C. Parslow, G. Joner, J. Svensson, C. Castell, P. J. Bingley, E. Schoenle, P. Jarosz-Chobot, B. Urbonaité, U. Rothe, C. Krzisnik, C. Ionescu-Tirgoviste, I. Weets, M. Kocova, G. Stipancic, M. Samardzic, C. E. de Beaufort, A Green, G. G. Dahlquist, G. Soltész

Erschienen in: Diabetologia | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of the study was to describe 20-year incidence trends for childhood type 1 diabetes in 23 EURODIAB centres and compare rates of increase in the first (1989–1998) and second (1999–2008) halves of the period.

Methods

All registers operate in geographically defined regions and are based on a clinical diagnosis. Completeness of registration is assessed by capture–recapture methodology. Twenty-three centres in 19 countries registered 49,969 new cases of type 1 diabetes in individuals diagnosed before their 15th birthday during the period studied.

Results

Ascertainment exceeded 90% in most registers. During the 20-year period, all but one register showed statistically significant changes in incidence, with rates universally increasing. When estimated separately for the first and second halves of the period, the median rates of increase were similar: 3.4% per annum and 3.3% per annum, respectively. However, rates of increase differed significantly between the first half and the second half for nine of the 21 registers with adequate coverage of both periods; five registers showed significantly higher rates of increase in the first half, and four significantly higher rates in the second half.

Conclusions/interpretation

The incidence rate of childhood type 1 diabetes continues to rise across Europe by an average of approximately 3–4% per annum, but the increase is not necessarily uniform, showing periods of less rapid and more rapid increase in incidence in some registers. This pattern of change suggests that important risk exposures differ over time in different European countries. Further time trend analysis and comparison of the patterns in defined regions is warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, the EURODIAB Study Group (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, the EURODIAB Study Group (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef
2.
Zurück zum Zitat The DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef The DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef
3.
Zurück zum Zitat Aamodt G, Stene LC, Njølstad PR, Søvik O, Joner G, Norwegian Childhood Diabetes Study Group (2007) Spatiotemporal trends and age-period-cohort modeling of the incidence of type 1 diabetes among children aged <15 years in Norway 1973–1982 and 1989–2003. Diabetes Care 30:884–889PubMedCrossRef Aamodt G, Stene LC, Njølstad PR, Søvik O, Joner G, Norwegian Childhood Diabetes Study Group (2007) Spatiotemporal trends and age-period-cohort modeling of the incidence of type 1 diabetes among children aged <15 years in Norway 1973–1982 and 1989–2003. Diabetes Care 30:884–889PubMedCrossRef
4.
Zurück zum Zitat Harjutsalo V, Lena Sjöberg S, Tuomilehto J (2008) Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371:1777–1782PubMedCrossRef Harjutsalo V, Lena Sjöberg S, Tuomilehto J (2008) Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371:1777–1782PubMedCrossRef
5.
Zurück zum Zitat Berhan Y, Waernbaum I, Lind T, Möllsten A, Dahlquist G, Swedish Childhood Diabetes Study Group (2011) Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 60:577–581PubMedCrossRef Berhan Y, Waernbaum I, Lind T, Möllsten A, Dahlquist G, Swedish Childhood Diabetes Study Group (2011) Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 60:577–581PubMedCrossRef
6.
Zurück zum Zitat Green A, Gale EAM, Patterson CC (1992) Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 339:905–909PubMedCrossRef Green A, Gale EAM, Patterson CC (1992) Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 339:905–909PubMedCrossRef
7.
Zurück zum Zitat Bishop YMM, Fienberg SE, Holland PW (1974) Discrete multivariate analysis: theory and practice. MIT Press, Cambridge, pp 231–237 Bishop YMM, Fienberg SE, Holland PW (1974) Discrete multivariate analysis: theory and practice. MIT Press, Cambridge, pp 231–237
8.
Zurück zum Zitat Dahlquist GG, Nystrom L, Patterson CC, the Swedish Childhood Diabetes Study Group and the Diabetes Incidence in Sweden Study Group (2011) Incidence of type 1 diabetes in Sweden among individuals aged 0–34 years, 1983–2007: an analysis of time trends. Diabetes Care 34:1754–1759 Dahlquist GG, Nystrom L, Patterson CC, the Swedish Childhood Diabetes Study Group and the Diabetes Incidence in Sweden Study Group (2011) Incidence of type 1 diabetes in Sweden among individuals aged 0–34 years, 1983–2007: an analysis of time trends. Diabetes Care 34:1754–1759
9.
Zurück zum Zitat Clayton D, Schifflers E (1987) Models for temporal variations in cancer rates II: age-period-cohort models. Stat Med 6:469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variations in cancer rates II: age-period-cohort models. Stat Med 6:469–481PubMedCrossRef
Metadaten
Titel
Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase
verfasst von
C. C. Patterson
E. Gyürüs
J. Rosenbauer
O. Cinek
A. Neu
E. Schober
R. C. Parslow
G. Joner
J. Svensson
C. Castell
P. J. Bingley
E. Schoenle
P. Jarosz-Chobot
B. Urbonaité
U. Rothe
C. Krzisnik
C. Ionescu-Tirgoviste
I. Weets
M. Kocova
G. Stipancic
M. Samardzic
C. E. de Beaufort
A Green
G. G. Dahlquist
G. Soltész
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 8/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2571-8

Weitere Artikel der Ausgabe 8/2012

Diabetologia 8/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.